The management of oral mucous membrane pemphigoid with dapsone and topical corticosteroid

Journal of Oral Pathology and Medicine

Volumn 37, Issue 6, 2008, Pages 341-344

  Arash, Azizi ^a,b   Shirin, Lawaf ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE   (Iran)

Author keywords

Corticosteroid; Dapsone; Mucous membrane pemphigoid; Pemphigus

Indexed keywords

DAPSONE; OINTMENT BASE; TRIAMCINOLONE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG POTENCY; EYE DISEASE; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; LOW DRUG DOSE; MALE; MONOTHERAPY; MOUTH MUCOSA; MOUTH ULCER; MUCOUS MEMBRANE PEMPHIGOID; ORAL BLISTER; PRIORITY JOURNAL; REMISSION; SIDE EFFECT; TREATMENT RESPONSE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DAPSONE; DRUG COMBINATIONS; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; ORAL ULCER; PEMPHIGOID, BULLOUS;

EID: 44949165443     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00653.x     Document Type: Article

References (14)

1. Greenberg M, Glick M. Burket's oral medicine, 10th ed. Philadelphia : JB Lippincott, 2003 72 3.
2. Lee BL, Medina I, Benowitz NL, et al. Dapsone, trimethoprim and sulfamethoxazole plasma levels during treatment of pneumo cystic pneumonix in patients with AIDS: evidence of drug interactions. Ann Intern Med 1989 110 : 606 11.
3. Coleman MD. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. Br J Dermatol 1993 129 : 507 13.
4. Rogers RS, Seehafer JR, Perry HO. Treatment of pemphigoid with dapsone. J Am Acad Dermatol 1982 6 : 215 23.
5. Rogers RS, Mehregan DA. Dapsone therapy of cicatrical pemphigoid. Semin Dermatol 1988 7 : 201 5
6. Mathews RN, Pinkney RCN, Scully C. The management of intrasigent desquamative gingivitis with dapsone. Ann Dent 1989 48 : 41 3.
7. Ciarrocca K, Greenberg M. A retrospective study of the management of oral mucous membrane pemphigoid with dapson. Oral Surg Oral Med Oral Pathol 1999 88 : 159 63.
8. Vincent SD, Lilly FE, Baker KA. Clinical, historic, and therapeutic features of cicatrical pemphigoid. Oral Surg Oral Med Oral Pathol 1993 76 : 453 9.
9. Nguyen QD, Foster CS. Cicatrical pemphigoid: diagnosis and treatment. Int Ophthalmol Clin 1996 36 : 41 60.
10. Debol SM, Herron MJ, Nelson RD. Anti-inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoatractant-induced signal transduction. J Leukoc Biol 1997 62 : 827 36.
11. Booth SA, Moody CE, Dahl MA, Herron MJ, Nelson RD. Dapsone suppresses integin-mediated neutrophil adherence function. J Invest Dermatol 1992 98 : 135 40.
12. Eversole LR. Immunopathology of oral mucosal ulcerative, desquamative, and bullous disease. Oral Surg Oral Med Oral Pathol 1994 77 : 555 71.
13. Sciubba JJ. Autoimmune aspects of pemphigus vulgaris and mucosal pemphigoid. Adv Dent Res 1996 10 : 52 6.
14. Prussick R, Shear NH. Dapson hypersensitivity syndrome. J Am Acad Dermatol 1996 35 : 346 9.